Shiok Meats Merges with Umami Bioworks

Agronomics Limited
13 March 2024
 

13 March 2024

Agronomics Limited

("Agronomics" or the "Company")

Shiok Meats Merges with Umami Bioworks

 

Agronomics (LSE: ANIC), a leading listed company focused on cellular agriculture, is pleased to announce that portfolio company Shiok Meats Pte. Ltd. ("Shiok Meats") has been acquired by UMAMI Bioworks Pte. Ltd. ("UMAMI Bioworks") in a share-for-share transaction.

 

UMAMI Bioworks is a Singapore-based company that uses novel stem cell technology, machine learning, and automation to produce cultivated seafood. This strategic combination aims to expedite the journey towards scalable production of sustainable, cultivated seafood. This merger leverages the unique strengths of UMAMI Bioworks' innovative production platform and enabling technologies and Shiok Meats' pioneering research in crustacean cell cultivation. Based in Singapore, the combined entity anticipates synergies that will enhance go-to-market efficiencies, expand commercial opportunities and accelerate regulatory approvals and market introduction of cultivated seafood.

 

As disclosed in the audited results for the year ending 30 June 2022, Agronomics' position in Shiok Meats was  fully written down. As a result of this transaction, Agronomics now holds an equity ownership of 0.71% in UMAMI Bioworks on a fully diluted basis. Subject to audit, this position will be carried forward at a book value of £ 0.378 million.

 

About UMAMI Bioworks

UMAMI Bioworks is a Singapore-headquartered company pioneering a standardized, modular, and automated production platform for cultivating 'not caught' seafood. It is bringing together novel stem cell biology, machine learning, and automation to create the operating system for cultivated seafood production, empowering traditional seafood suppliers to produce a stable, resilient, local supply of culturally relevant seafood products free from mercury, antibiotics, microplastics, and ocean pollutants. UMAMI Bioworks is dedicated to regenerating our oceans and our planet by enabling consumers to access delicious, affordable, nutritious seafood from culturally important, prized species while providing a sustainable alternative to the overfishing of ETP (endangered, threatened, and protected) species. For more information, please visit: https://www.umamibioworks.com.

 

About Shiok Meats

Shiok Meats is a cultivated meat and seafood company - the first of its kind in Singapore and South-East Asia. "Shiok" in Singapore and Malay slang means fantastic, delicious, and simply, pleasure. Shiok Meats also owns SEA's first cultivated red meat company, Gaia Foods. Its mission is to bring delicious, sustainable, and healthy seafood to the table, using its technology to grow meat from healthy cells instead of animals. To date, Shiok has conducted R&D on crustaceans like shrimps, crabs, and lobsters and is the first in the world to do so using cellular agriculture technology. The company raised funding of US$ 30 million from notable investors like Aqua-Spark, SEEDS capital, Toyo Seikan, Real Tech Holdings, Big Idea Ventures, Y Combinator, Entrepreneur First, AiiM Partners and Henry Soesanto of Monde Nissin, to name a few. More information is available at www.shiokmeats.com.

 

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford
 Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings